Patent Ductus Arteriosus Cyclooxygenase Inhibitor VLBW Infant Persist Ductus Arteriosus ELBW Infant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Barrington K, Brion LP. Dopamine versus no treatment to prevent renal dysfunction in Indomethacin-treated preterm newborn infants. The Cochrane Library 1, 2002.Google Scholar
  2. 2.
    Fowlie PW, Davis PG. Prophylactic intravenous Indomethacin for preventing mortality and morbidity in preterm infants. The Cochrane Library 2, 2002.Google Scholar
  3. 3.
    Cooke L, Steer P, Woodgate P. Indomethacin for asymptomatic patent ductus arteriosus in preterm infants. The Cochrane Library 3, 2002.Google Scholar
  4. 4.
    Shah SS, Ohlsson A. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants. The Cochrane Library 1, 2003.Google Scholar
  5. 5.
    Ohlsson A, Walia R, Shah S. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infents. The Cochrane Library 1, 2003.Google Scholar
  6. 6.
    Malviya M, Ohlsson A, Shah S. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants. The Cochrane Library 2, 2003.Google Scholar
  7. 7.
    Crowley P. Prophylactic corticosteroids for preterm birth. The Cochrane Library 1, 1996.Google Scholar
  8. 8.
    Hammerman C. Patent Ductus Arteriosus. Clinical relevance or prostaglandins and prostaglandin inhibitors in PDA pathophysiology and treatment. Clin Perinatol 1995; 22: 457–79.PubMedGoogle Scholar
  9. 9.
    van Overmeire B, Suys B. Pharmacological manipulation of patent ductus arteriosus. In: Les medicaments en reanimation neonatale. Springer Verlag 1999, 141–71.Google Scholar
  10. 10.
    Bell EF, Acarregui MJ. Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. The Cochrane Library 2, 2001.Google Scholar
  11. 11.
    Ment LR, Oh W, Ehrenkranz RA, Philip AG, Allan W, Duncan CC, Scott DT, Taylor KJ, Katz KH. Low-Dose Indomethacin and prevention of intraventricular hemorrhage: A multicenter randomized trial. Pediatrics 1994; 93: 543–50.PubMedGoogle Scholar
  12. 12.
    Ment LR, Vohr B, Scott DT, Allan WC, Westerveld M, Duncan CC, Ehrenkranz RA, Katz KH, Schneider KC, Makuch RW. Neurodevelopmental outcome at 36 months’ corrected age of preterm infants in the Multicenter Indomethacin Intraventricular Hemorrhage Prevention Trial. Pediatrics 1996; 98: 714–18.PubMedGoogle Scholar
  13. 13.
    Vohr BR et al. School-age outcomes of very low birth weight infants in the Indomethacin intraventricular hemorrhage prevention trial, Pediatrics 2003; 111: e340–e346.CrossRefPubMedGoogle Scholar
  14. 14.
    Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S, Solimano A, Vincer M, Wright LL, for the Trial of Indomethacin Prophylaxis in Preterms Investigators. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. New Engl J Med 2001; 344: 1966–72.CrossRefPubMedGoogle Scholar
  15. 15.
    Gournay V, Savagner C, Thiriez G, Kuster A, Rozé JC. Pulmonary hypertension after ibuprofen prophylaxis in very preterm infants. Lancet 2002; 359: 1486–1488.CrossRefPubMedGoogle Scholar
  16. 16.
    Patel J Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of Ibuprofen with Indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res 2000; 47: 36–42.PubMedGoogle Scholar
  17. 17.
    Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, De Groote K, Langhendries JP. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. New Engl J Med 2000; 343: 674–681.CrossRefPubMedGoogle Scholar
  18. 18.
    Heymann MA, Rudoph AM, Silverman NH: Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. New Engl J Med 1976; 295: 530–533.PubMedCrossRefGoogle Scholar
  19. 19.
    Coceani F, White E, Bodach E, Olley PM. Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and Ibuprofen. Can J Physiol Pharmacol 1979; 57: 825–31.PubMedGoogle Scholar
  20. 20.
    von der Wense A, Laux R, Süßenguth R. Ibuprofentherapie des persistierenden Ductus arteriosus Botalli bei Frühgeborenen mit sehr niedrigem Geburtsgewicht. Z Geburth Neonatol 2003; 207,Suppl 1: 17.Google Scholar
  21. 21.
    Stevenson JG. Fluid administration in the ssociation of patent ductus arteriosus complicating respiratory distress syndrome. J Pediatr 1977; 90: 257–61.PubMedGoogle Scholar
  22. 22.
    Osborn DA, Evans N: Early volume expansion for prevention of morbidity and mortality in very preterm infants. The Cochrane Database of Systematic Reviews 2004; Issue 2: CD002055.Google Scholar

Copyright information

© Springer Medizin Verlag Heidelberg 2005

Authors and Affiliations

  • Axel von der Wense
    • 1
  1. 1.Department of Neonatology and Pediatric Intensive CareAltonaer Kinder-KrankenhausHamburg

Personalised recommendations